bioRxiv/medRxiv TRiP Review Activity

285 Reviews — eLife — Cancer Biology

Most recent first Previous |  Page 14: Articles 131-140  | Next

RAPSYN-Mediated Neddylation of BCR-ABL Alternatively Determines the Fate of Philadelphia Chromosome-positive Leukemia
Zhao, m., Dai, B., Li, X., Zhang, Y., Qiao, C., Qin, Y., Li, Z., Li, Q., Wang, S., Yang, Y., Chen, Y.
10.1101/2023.05.24.542110 — Posted: 2023-05-25 — Discussion: 2024-05-02  eLife
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A. A. I., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., Crowder, K. D., Kent, J. R., Madariaga, M. L. L., Jain, R. K., Beckermann, K. E., Lewis, C. A., Clish, C. B., Muir, A., Rathmell, W. K., Rathmell, J. C., Vander Heiden, M. G.
10.1101/2023.12.24.573250 — Posted: 2023-12-24 — Discussion: 2024-04-30  eLife
mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated non-degradative ubiquitination of eIF4A1
Sun, H., Jiao, D., Zhao, X., Chen, Y., Shi, Q., Lv, Z., Li, Y., Gao, K., Wang, C.
10.1101/2023.09.27.559872 — Posted: 2023-09-29 — Discussion: 2024-04-26  eLife
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Howard, G. C., Wang, J., Rose, K. L., Patel, P., Tsui, T., Florian, A. C., Lorey, S. L., Grieb, B. C., Smith, B. N., Slota, M. J., Reynolds, E. M., Goswami, S., Savona, M. R., Lee, T., Fesik, S. W., Liu, Q., Tansey, W. P.
10.1101/2023.07.26.550648 — Posted: 2023-07-29 — Discussion: 2024-04-09  eLife
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers
Pineda, J. M. B., Bradley, R. K.
10.1101/2023.07.10.548412 — Posted: 2023-07-11 — Discussion: 2024-04-08  eLife
mitoBKCa is functionally expressed in murine and human breast cancer cells and promotes metabolic reprogramming
Bischof, H., Maier, S., Koprowski, P., Kulawiak, B., Burgstaller, S., Jasinska, J., Serafimov, K., Gross, D., Schroth, W., Matt, L., Juarez Lopez, D. A., Bonzheim, I., Büttner, F. A., Fend, F., Schwab, M., Birkenfeld, A. L., Malli, R., Lämmerhofer, M., Bednarczyk, P., Szewczyk, A., Lukowski, R.
10.1101/2023.10.02.560571 — Posted: 2023-10-04 — Discussion: 2024-04-05  eLife
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
Mullen, N. J., Shukla, S. K., Thakur, R., Kollala, S. S., Wang, D., Chaika, N., LaBreck, D. A., Mallareddy, J. R., Price, D., Natarajan, A., Mehla, K., Sykes, D. B., Hollingsworth, M. A., Singh, P. K.
10.1101/2023.04.03.535399 — Posted: 2023-04-05 — Discussion: 2024-04-04  eLife
Single cell multi-omics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response
Warfvinge, R., Geironson Ulfsson, L., Dhapola, P., Safi, F., Sommarin, M. N. E., Soneji, S., Hjorth-Hansen, H., Mustjoki, S., Richter, J., Krishna Thakur, R., Karlsson, G.
10.1101/2023.08.16.553504 — Posted: 2023-08-18 — Discussion: 2024-04-04  eLife
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
Zhang, L., Hsu, J. I., Braekeleer, E. D., Chen, C.-w., Patel, T. D., Urya, H., Guzman, A. G., Martell, A. G., Waldvogel, S. M., Tovy, A., Callen, E., Murdaugh, R. L., Richard, R. U., Jansen, S., Vissers, L., de Vries, B. B., Nussenzweig, A., Huang, S., Coarfa, C., Anastas, J. N., Takahashi, K., Vassiliou, G. S., Goodell, M. A.
10.1101/2023.08.31.555634 — Posted: 2023-09-01 — Discussion: 2024-04-02  eLife
CYRI-B mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake
Nikolaou, S., Juin, A., Whitelaw, J. A., Paul, N. R., Fort, L., Nixon, C., Spence, H. J., Bryson, S., Machesky, L. M.
10.1101/2022.11.23.517689 — Posted: 2022-11-24 — Discussion: 2024-03-27  eLife

Evaluation Sources